Rindone, J. P., & Mellen, C. K. (2024). Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction. European Journal of Clinical Pharmacology, 80(8), 1113. https://doi.org/10.1007/s00228-024-03686-6
Chicago-referens (17:e uppl.)Rindone, Joseph P., och Chadwick K. Mellen. "Sacubitril/valsartan Compared to Equivalent/sub-equivalent Dose Angiotensin Receptor Blocker or Angiotensin-converting Enzyme Inhibitor in Heart Failure with Reduced Ejection Fraction." European Journal of Clinical Pharmacology 80, no. 8 (2024): 1113. https://doi.org/10.1007/s00228-024-03686-6.
MLA-referens (9:e uppl.)Rindone, Joseph P., och Chadwick K. Mellen. "Sacubitril/valsartan Compared to Equivalent/sub-equivalent Dose Angiotensin Receptor Blocker or Angiotensin-converting Enzyme Inhibitor in Heart Failure with Reduced Ejection Fraction." European Journal of Clinical Pharmacology, vol. 80, no. 8, 2024, p. 1113, https://doi.org/10.1007/s00228-024-03686-6.
